Norepinephrine-deficient mice have increased susceptibility to seizure- inducing stimuli

Journal of Neuroscience

Volumn 19, Issue 24, 1999, Pages 10985-10992

  Szot, Patricia ^a,c,d   Weinshenker, David ^a,b   White, Sylvia S ^a   Robbins, Carol A ^a   Rust, Nicole C ^a,b   Schwartzkroin, Philip A ^a,b   Palmiter, Richard D ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c GRECC   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

C fos mRNA; Dopamine hydroxylase; Epilepsy; Flurothyl; Kainic acid; Norepinephrine; Seizure

Indexed keywords

DOPAMINE BETA MONOOXYGENASE; FLUROTHYL; KAINIC ACID; NORADRENALIN; PENTETRAZOLE; PROTEIN C FOS;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; EPILEPTOGENESIS; FEMALE; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; SEIZURE;

EID: 0033573459     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-24-10985.1999     Document Type: Article

References (76)

1. Arnold PS, Racine RJ, Wise RS (1973) Effects of atropine, reserpine, 6-hydroxydopamine and handling on seizure development in the rat. Exp Neurol 40:457-470.
2. Aston-Jones G, Bloom FE (1981) Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1:876-886.
3. Baraban SC, Hollopeter G, Erickson JC, Schwartzkroin PA, Palmiter RD (1997) Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J Neurosci 17:8927-8936.
4. Baran H, Sperk G, Hortnagl H, Sapetschnig G, Hornykiewicz O (1985) Alpha 2-adrenoceptors modulate kainic acid-induced limhic seizures. Eur J Pharmacol 113:263-269.
5. Browning RA (1985) Role of the brain-stem reticular formation in tonic-clonic seizures: lesions and pharmacological studies. Fed Proc 44:2425-2431.
6. Browning RA, Wade DR, Marcinczyk M, Long GL, Jobe PC (1989) Regional brain abnormalities in norepinephrine uptake and dopamine β-hydroxylase activity in the genetically epilepsy-prone rat. J Pharmacol Exp Ther 249:229-235.
7. Chen G, Ensor GR, Bohner B (1954) A facilitation action of reserpine on the central nervous system. Proc Soc Exp Biol Med 86:507-510.
8. Cirelli C, Pompeiano M, Tononi G (1996) Neuronal gene expression in the waking state: a role for the locus coeruleus. Science 274:1211-1215.
9. Curet O, deMontigny C (1988) Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. I. Receptors mediating the effect of microiontophoretically applied norepinephrine. Brain Res 475:35-46.
10. Curran T, Gordon MB, Rubino KL, Sambucetti LC (1987) Isolation and characterization of the c-fos (rat) cDNA and analysis of post-translational modifications in vitro. Oncogene 2:79-84.
11. Dailey JW, Jobe PC (1986) Indices of noradrenergic function in the central nervous system of seizure-naive genetically epilepsy-prone rats. Epilepsia 27:665-670.
12. Dailey JW, Mishra PK, Ko KH, Penny JE, Jobe PC (1991) Noradrenergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Epilepsia 32:168-173.
13. Dailey JW, Mishra PK, Ko KH, Penny JE, Jobe PC (1992) Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Life Sci 50:319-326.
14. Dichter MA (1994) Emerging insights into mechanisms of epilepsy: implications for new antiepileptic drug development. Epilepsia 35[Suppl 4]:s51-s57.
15. Dragunow M, Robertson HA (1987) Kindling stimulation induces c-fos protein(s) in granule cells of the rat dentate gyrus. Nature 329:441-442.
16. Erickson JC, Clegg KE, Palmiter RD (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381:415-421.
17. Faingold CL, Gehlach B, Caspary DM (1986) Decreased effectiveness of GABA-mediated inhibition in the inferior colliculus of the genetically epilepsy-prone rat. Exp Neurol 93:145-159.
18. Fallon JH, Loughlin SE (1982) Monoamine innervation of the forebrain: collateralization. Brain Res Bull 9:295-307.
19. Fletcher A, Forster EA (1988) A proconvulsant action of selective α2-adrenoceptor antagonists. Eur J Pharmacol 151:27-34.
20. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. New York: Academic.
21. Hara M, Sasa M, Kawabata A, Serikawa T, Yamada T, Yamada J, Takaori S (1993) Decreased dopamine and increased norepinephrine levels in the spontaneously epileptic rat, a double mutant rat. Epilepsia 34:433-440.
22. Hobson JA, McCarley RW, Wyzinski PW (1975) Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 189:55-58.
23. Jackson HC, Dickinson SL, Nutt DJ (1991) Exploring the pharmacology of the pro-convulsant effects of alpha 2-adrenoceptor antagonists in mice. Psychopharmacology (Berl) 105:558-562.
24. Janumpalli S, Butler LS, MacMillan LB, Limbird LE, McNamara JO (1998) A point mutation (D79N) of the alpha2a-adrenergic receptor abolishes the antiepileptic action of endogenous norepinephrine. J Neurosci 18:2004-2008.
25. Jerlicz M, Kostowski W, Bidzi'nski A, Hauptman M, Dymecki J (1978) Audiogenic seizures in rats: relation to noradrenergic neurons of the locus coeruleus. Acta Physiol Pol 29:409-412.
26. Jobe PC, Ko KH, Dailey JW (1984) Abnormalities in norepinephrine turnover rate in the central nervous system of the genetically epilepsy-prone rat. Brain Res 290:357-360.
27. Jouvet M (1969) Biogenic amines and the states of sleep. Science 163:32-41.
28. King GA, Burnham WM (1982) Alpha 2-adrenergic antagonists suppress epileptiform EEG activity in a petit mal seizure model. Life Sci 30:293-298.
29. Kleinrok Z, Gustaw J, Czuczwar SJ (1991) Influence of antidepressant drugs on seizure susceptibility and the anticonvulsant activity of valproate in mice. J Neural Transm [Suppl] 34:85-90.
30. Langmoen IA, Segal M, Andersen P (1981) Mechanisms of norepinephrine actions on hippocampal pyramidal cells in vitro. Brain Res 208:349-362.
31. Lapin IP, Ryzor IV (1990) Effect of catecholaminergic drugs on quinolinate- and kynurenine-induced seizures in mice. J Neurol Transm Gen Sect 82:55-65.
32. Lauterborn JC, Ribak CR (1989) Differences in dopamine beta-hydroxylase immunoreactivity between the brains of genetically epilepsy-prone and Sprague-Dawley rats. Epilepsy Res 4:161-176.
33. L'Heureux R, Dennis T, Curet O, Scatton B (1986) Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis: effects of drugs affecting noradrenergic transmission. J Neurochem 46:1794-1801.
34. Libet B, Gleason CA, Wright EW, Feinstein B (1977) Suppression of an epileptiform type of clectrocortical activity in the rat by stimulation of the locus coeruleus. Epilepsia 18:451-462.
35. Licata F, Li-Volsi G, Maugeri G, Ciranna L, Santangelo F (1993) Effects of noradrenaline on the firing rate of vestibular neurons. Neuroscience 53:149-158.
36. Loscher W, Czuczwar SJ (1987) Comparison of drugs with different selectivity for central alpha1- and alpha2-adrenoceptors in animal models of epilepsy. Epilepsy Res 1:165-172.
37. Loughlin SE, Foote SL, Fallon JH (1982) Locus coeruleus projections to cortex: topography, morphology and collateralizations. Brain Res Bull 9:287-294.
38. MacMillan LB, Hein L, Smith MS, Piascik MT, Limbird LE (1996) Central hypotensive effects of the α2a-adrenergic receptor subtype. Science 273:801-803.
39. Madison DV, Nicoll RA (1986) Actions of noradrenaline recorded intracellularly in rat hippocampal CA1 pyramidal neurons in vitro. J Physiol (Lond) 372:221-244.
40. Mason ST, Corcoran M E (1979) Catecholamines and convulsions. Brain Res 170:497-507.
41. Mazarati AM, Hal'aszi E, Telegdy G (1992) Anticonvulsive effects of galanin administered into the central nervous system upon the picrotoxin-kindled seizure syndrome in rats. Brain Res 589:164-166.
42. Mazarati AM, Liu H, Soomets U, Sankar R, Shin D, Katsumori H, Langel U, Wasterlain CG (1998) Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. J Neurosci 18:10070-10077.
43. Meyerhoff JL, Carter RE, Yourick DL, Slusher BS, Coyle JT (1992) Genetically epilepsy-prone rats have increased brain regional activity of an enzyme which liberates glutamate from N-acetyl-aspartyl-glutamate. Brain Res 593:140-143.
44. Mishra PK, Burger RL, Bettendorf AF, Browning RA, Johe PC (1994) Role of norepinephrine in forebrain and brainstem seizures: chemical lesioning of locus ceruleus with DSP4. Exp Neurol 125:58-64.
45. Morgan JI, Curran T (1991) Proto-oncogene transcription factors and epilepsy. Trends Pharmacol Sci 12:343-349.
46. Morgan JI, Cohen DR, Hempstead JL, Curran T (1987) Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237:192-197.
47. Murray TF, Sylvester D, Schultz CS, Szot P (1985) Purinergic modulation of pentylenetetrazol seizure threshold in the rat. Neuropharmacology 24:761-766.
48. Nishi H, Watanabe S, Ueki S (1981) Effects of monoamines injected into the hippocampus on hippocampal seizure discharges in the rabbit. J Pharmacobiodyn 4:7-14.
49. Noebels JL (1986) Mutational analysis of inherited epilepsies. Adv Neurol 44:97-113.
50. Olney JW, Rhee V, Ho OL (1974) Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res 77:507-512.
51. Papanicolaou J, Summers RJ, Vajda FJE, Louis WJ (1982) The relationship between alpha 2-adrenoceptor selectivity and anticonvulsant effect in a series of clonidine-like drugs. Brain Res 241:393-397.
52. Parfitt KD, Freedman R, Bickford-Wimer PC (1988) Electrophysiological effects of locally applied noradrenergic agents at cerebellar Purkinje neurons: receptor specificity. Brain Res 462:242-251.
53. Prichard JW, Gallagher BB, Glaser GH (1969) Experimental seizure-threshold testing with flurothyl. J Pharmacol Exp Ther 166:170-178.
54. Robbins CA, Kim DW, Szot P, Rho JM, White SS, Schwartzkroin PA (1998) c-Fos mRNA expression is increased in mouse brain after seizure induced by flurothyl. Epilepsia 39(Suppl 6]:26.
55. Robbins TW (1984) Cortical noradrenaline, attention and arousal. Psychol Med 14:13-21.
56. Schwob JE, Fuller T, Price JL, Olney JW (1980) Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study. Neuroscience 5:991-1014.
57. Segal M (1981) The action of norepinephrine in the rat hippocampus: intracellular studies in the slice preparation. Brain Res 206:107-128.
58. Snead III OC (1987) Noradrenergic mechanisms in gamma-hydroxybulyrate-induced seizure activity. Eur J Pharmacol 136:103-108.
59. Snead III OC (1992) Pharmacological models of generalized absence seizures in rodents. J Neural Transm Suppl 35:7-19.
60. Sonnenberg JL, Mitchelmore C, McGregor-Leon PF, Hempstead J, Morgan JI, Curran T (1989) Glutamate receptor agonists increase the expression of Fos, Fra and AP-1 DNA binding activity in the mammalian brain. J Neurosci Res 24:72-80.
61. Stanton PK (1992) Noradrenergic modulation of epileptiform bursting and synaptic plasticity in the dentate gyrus. Epilepsy Res Suppl 7:135-150.
62. Sullivan HC, Osorio I (1991) Aggravation of penicillin-induced epilepsy in rats with locus ceruleus lesion. Epilepsia 32:591-596.
63. Szahadi E (1979) Adrenoccptors on central neurons: microelectro-phoretic studies. Neuropharmacology 18:831-843.
64. Szot P, White SS, Veith RC (1997) Effect of pentylenetetrazol on the expression of tyrosine hydroxylase mRNA and norepinephrine and dopamine transporter mRNA. Mol Brain Res 44:46-54.
65. Tacke U, Kolonen S (1984) The effect of clonidine and yohimbine on audiogenic seizures (AGS) in rats. Pharmacol Res Commun 16:1019-1030.
66. Thomas SA, Palmiter RD (1997a) Disruption of the dopamine β-hydroxylase gene in mice suggests roles for norepinephrine in motor function, learning, and memory. Behav Neurosci 111:579-589.
67. Thomas SA, Palmiter RD (1997b) Thermoregulatory and metabolic phenotypes of mice lacking noradrenaline. Nature 387:94-97.
68. Thomas SA, Palmiter RD (1997c) Impaired maternal behavior in mice lacking norepinephrine and epinephrine. Cell 91:583-592.
69. Thomas SA, Matsumoto AM, Palmiter RD (1995) Noradrenaline is essential for mouse fetal development. Nature 374:643-646.
70. Thomas SA, Marck BT, Palmiter RD, Matsumoto AM (1998) Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine β-hydroxylase. J Neurochem 70:2468-2476.
71. Trottier S, Lindvall O, Chauvel P, Bjorklund A (1988) Facilitation of focal cobalt-induced epilepsy after lesions of the noradrenergic locus coeruleus system. Brain Res 454:308-314.
72. Turski L, Ikonomidou C, Turski WA, Bortolotto ZA, Cavalheiro ES (1989) Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 3:154-171.
73. Waterhouse BD (1986) Electrophysiological assessment of monoamine synaptic function in neuronal circuits of seizure susceptible brains. Life Sci 39:807-818.
74. 14C]2-deoxyglucose uptake and Fos immunocytochemistry. J Neurosci 13:4787-4809.
75. Woodbury DM (1980) Convulsant drugs: mechanism of action. Adv Neurol 27:249-303.
76. Yacobi R, Burnham WM (1991) The effect of tricyclic antidepressants on cortex- and amygdala-kindled seizures in the rat. Can J Neurol Sci 18:132-136.